MG
ACAD icon

Mather Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Mather Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$1.85K – 1709
2024
Q2 		$1.85K Buy
+100
New +$1.85K ﹤0.01% 1903